Metser U - Search Results

1

Association of Free-to-Total PSA Ratio and ¹⁸F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study.

Bernardino RM, Lajkosz K, Yin LB, Sayyid RK, Wettstein M, Randhawa H, Cockburn JG, Ahmed S, Thomassian R, Diamandis E, Metser U, Berlin A, Fleshner NE. Bernardino RM, et al. Among authors: metser u. J Nucl Med. 2024 Nov 1;65(11):1731-1739. doi: 10.2967/jnumed.124.267877. J Nucl Med. 2024. PMID: 39327019

2

Detection of urothelial tumors: comparison of urothelial phase with excretory phase CT urography--a prospective study.

Metser U, Goldstein MA, Chawla TP, Fleshner NE, Jacks LM, O'Malley ME. Metser U, et al. Radiology. 2012 Jul;264(1):110-8. doi: 10.1148/radiol.12111623. Epub 2012 Apr 10. Radiology. 2012. PMID: 22495683

3

18F-FDG-PET/CT in the Staging and Management of Melanoma: A Prospective Multicenter Ontario PET Registry Study.

Singnurkar A, Wang J, Joshua AM, Langer DL, Metser U. Singnurkar A, et al. Among authors: metser u. Clin Nucl Med. 2016 Mar;41(3):189-93. doi: 10.1097/RLU.0000000000000996. Clin Nucl Med. 2016. PMID: 26447374

4

Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake.

Metran-Nascente C, Yeung I, Vines DC, Metser U, Dhani NC, Green D, Milosevic M, Jaffray D, Hedley DW. Metran-Nascente C, et al. Among authors: metser u. J Nucl Med. 2016 Mar;57(3):361-6. doi: 10.2967/jnumed.115.167650. Epub 2016 Jan 14. J Nucl Med. 2016. PMID: 26769863 Free article.

5

Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.

Metser U, Halankar J, Langer D, Mohan R, Hussey D, Hadas M, Tamir S. Metser U, et al. Ann Nucl Med. 2017 Feb;31(2):153-162. doi: 10.1007/s12149-016-1139-y. Epub 2016 Nov 15. Ann Nucl Med. 2017. PMID: 27848159

6

Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review.

Singnurkar A, Poon R, Metser U. Singnurkar A, et al. Among authors: metser u. Ann Nucl Med. 2017 Jun;31(5):366-378. doi: 10.1007/s12149-017-1164-5. Epub 2017 Mar 28. Ann Nucl Med. 2017. PMID: 28353197 Review.

7

Benign Cutaneous and Subcutaneous Lesions on FDG-PET/CT.

Metser U, Tau N. Metser U, et al. Semin Nucl Med. 2017 Jul;47(4):352-361. doi: 10.1053/j.semnuclmed.2017.02.007. Epub 2017 Apr 11. Semin Nucl Med. 2017. PMID: 28583275 Review.

8

¹⁸F-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer.

Metser U, Berlin A, Halankar J, Murphy G, Jhaveri KS, Ghai S, Tau N. Metser U, et al. AJR Am J Roentgenol. 2018 Mar;210(3):635-640. doi: 10.2214/AJR.17.18567. Epub 2018 Jan 11. AJR Am J Roentgenol. 2018. PMID: 29323548

9

¹⁸F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.

Parvez A, Tau N, Hussey D, Maganti M, Metser U. Parvez A, et al. Among authors: metser u. Ann Nucl Med. 2018 Jul;32(6):410-416. doi: 10.1007/s12149-018-1260-1. Epub 2018 May 12. Ann Nucl Med. 2018. PMID: 29754276

10

Quantitative assessment of dynamic ¹⁸F-flumethycholine PET and dynamic contrast enhanced MRI in high risk prostate cancer.

Tau N, Berlin A, Yeung I, Halankar J, Murphy G, Jhaveri KS, Ghai S, Metser U. Tau N, et al. Among authors: metser u. Br J Radiol. 2019 Feb;92(1094):20180568. doi: 10.1259/bjr.20180568. Epub 2018 Nov 14. Br J Radiol. 2019. PMID: 30383459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters